Dr. Martin Landsberger studied biology, chemistry and educational sciences at the University of Munich from 1988 to 1994. He was a research associate at the Institute of Botany, University of Munich, and obtained his doctoral degree in 1999. After a postdoctoral position at the University of Southampton, United Kingdom, he became assistant lecturer in the Department of Internal Medicine at the University of Greifswald in 2000, and set up his own group “Molecular Cardiology” working on pathophysiology and pharmacotherapy of cardiovascular diseases.

Dr. Landsberger has published a large number of scientific publications and has successfully applied for research funding, e.g. DFG, and BMBF. He has given lectures on pharmacology and pathophysiology and supervised a large number of doctoral and master theses.

His technical specializations are pharmacology, molecular biology, cell biology, biochemistry, biotechnology, and gene technology.

Dr. Landsberger advises international clients in the areas of pharmacology, molecular biology, medical products, cell biology, biochemistry, biotechnology and genetic technology.

Dr. Landsberger is a member of VBIO, DGK, and GfMVB.